BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of 0.75% convertible senior notes ...

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

In today’s Pharma Pulse, President Trump unveils a patient payment plan, the FDA flags a rare seizure risk for several ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...

Inside Fosun Pharma's ambition to be a global drug company; Vaccine exemptions for religious or personal beliefs continue to ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

We came across a bullish thesis on Ascendis Pharma A/S on Tip Ranks’ YouTube Channel. In this article, we will summarize the ...

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...

Though far from the first large drugmaker to strike a pricing deal with the Trump administration, AbbVie’s new accord is ...

On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his ...

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.